Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes

The purpose of this formative study is to provide preliminary data regarding how the availability of menthol flavored e-cigarettes affects tobacco use behavior in the context of a ban on menthol flavored cigarettes

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tobacco Use Disorder Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinical and Translational Sciences Institute

Minneapolis, Minnesota, 55455, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Self identify as African American
smoke primarily menthol cigarettes
be between the ages of 18 and 64
smoke a minimum number of cigarettes per day
agree to abstain from menthol cigarettes for an 8 week period

Exclusion criteria

current unstable medical / psychiatric condition
regular use any form of nicotine or tobacco other than cigarettes
are pregnant or breast feeding

The investigators will evaluate if there are other reasons why someone may not be eligible to participate

Treatment and study plan

menthol flavored e-cigarette

Other

menthol flavored e-cigarette

tobacco flavored e-cigarette

Other

tobacco flavored e-cigarette

Primary outcomes

Number of Cigarettes Smoked Per Day

Time frame: 1 month

Number of cigarettes smoked per day as self-reported on tobacco diary
Number of E-cigarette Puffs Used Per Day

Time frame: 1 month

Self-reported number of puffs of e-cigarettes used per day

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Important dates

Study start: 2017
Primary completion: 2019
Study completion: 2019
First posted: May 23, 2017
Registry last updated: Jul 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed